XPOVIO® (selinexor) 20mg tablet

    is NOW FDA-APPROVED to treat adults with certain types of dif‌fuse large B-cell lymphoma (DLBCL) that has come back (relapsed) or that did not respond to previous treatment (refractory) and who have received at least 2 prior therapies.1

    Talk to your healthcare provider to see if XPOVIO® (selinexor) is right for you.

    Reference: 1. XPOVIO (selinexor) [package insert]. Newton, MA: Karyopharm Therapeutics Inc.; June 2020.

    XPOVIO® (selinexor) | Relapsed Refractory DLBCL